In addition, Sun et al. (2021) reported that p53 regulates cholesterol synthesis by inhibiting the transcription of SQLE, thus exerting an inhibitory effect on NAFLD-related HCC. The gene discussed is TP53; the disease is hepatocellular carcinoma.